Acute Invasive Rhino-Orbital Mucormycosis in a Patient With COVID-19-Associated Acute Respiratory Distress Syndrome
-
- Zesemayat K. Mekonnen
- School of Medicine
-
- Davin C. Ashraf
- Department of Ophthalmology
-
- Tyler Jankowski
- Department of Pathology, University of California, San Francisco
-
- Seanna R. Grob
- Department of Ophthalmology
-
- M. Reza Vagefi
- Department of Ophthalmology
-
- Robert C. Kersten
- Department of Ophthalmology
-
- Jeffry P. Simko
- Department of Pathology, University of California, San Francisco
-
- Bryan J. Winn
- Department of Ophthalmology
書誌事項
- 公開日
- 2020-11-19
- DOI
-
- 10.1097/iop.0000000000001889
- 公開者
- Ovid Technologies (Wolters Kluwer Health)
この論文をさがす
説明
<jats:p>Acute invasive fungal rhinosinusitis is a rare, although highly morbid, infection primarily affecting immunosuppressed individuals. The same population is at particularly high risk of complications and mortality in the setting of SARS-CoV-2 infection and coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome. The authors present a case of acute invasive fungal rhino-orbital mucormycosis in a patient with COVID-19 and discuss the prevalence, diagnosis, and treatment of fungal coinfections in COVID-19. Prompt recognition, initiation of therapy, and consideration of the challenges of rapidly evolving COVID-19 therapy guidelines are important for improving patient survival.</jats:p>
収録刊行物
-
- Ophthalmic Plastic & Reconstructive Surgery
-
Ophthalmic Plastic & Reconstructive Surgery 37 (2), e40-e80, 2020-11-19
Ovid Technologies (Wolters Kluwer Health)